3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
118
Myelodysplastic Syndromes
37
Hodgkin Disease
35
Leukemia, Myeloid, Acute
33
Lymphoma
31
Lymphoma, Non-Hodgkin
30
Neoplasms, Plasma Cell
28
Precursor Cell Lymphoblastic Leukemia-Lymphoma
26
Leukemia
26
Leukemia, Lymphocytic, Chronic, B-Cell
23
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
22
Myeloproliferative Disorders
19
Hematologic Neoplasms
18
Primary Myelofibrosis
17
Recurrence
12
Anemia, Aplastic
12
Lymphoma, Follicular
11
Lymphoma, Mantle-Cell
10
Graft vs Host Disease
10
Lymphoma, B-Cell, Marginal Zone
9
Hematologic Diseases
9
Burkitt Lymphoma
9
Leukemia, Prolymphocytic
8
Leukemia, Plasma Cell
8
Leukemia, Myelomonocytic, Chronic
8
Anemia, Refractory, with Excess of Blasts
6
Polycythemia Vera
4
Ovarian Neoplasms
4
Lymphoma, B-Cell
4
Waldenstrom Macroglobulinemia
3
Interventions
fludarabine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
×
fludarabine
×
Plasma cell
×
Clear all
NCT04561557
2024-10-30
CARTinNS
Tongji Hospital
Phase EARLY_PHASE1
Recruiting
36 enrolled